RxDoctor Payments Data

Anna Greka, MD

Internal Medicine · Boston, MANPI 1679672596

Payments from drug & device makers

$20,854in general payments, 2019–2025

Across 8 payments — averaging $2606.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$10K
  • Merck$3K
  • Akebia Therapeutics Inc$2K
  • Gilead$2K
  • Chugai Pharmaceutical Co., Ltd.$2K
  • Pfizer$1K
  • plus $1K from 2 others

What the payments were for

  • Consulting fees$9,75487%
  • Speaking & faculty fees$1,41113%

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,854 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$5,190
Medicare patients
12
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →